RMTI
Rockwell Medical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.99
+0.00%Margins
Gross margin
17.7%
EBITDA margin
-3.4%
EBIT margin
-6.5%
Net margin
-7.3%
FCF margin
2.2%
-14.5%
Return on equity
-9.0%
Return on assets
-9.2%
Return on invested capital
1.22x
Asset turnover
$2.9M
Cash from operations
$6.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026